The University of Tennessee Health Science Center shared a post on LinkedIn:
“Since becoming a doctor, Kenneth Ataga, goals have always been the same: help patients with sickle cell disease live as normal a life as possible.
‘We try and provide medical care to help them live as normal a life as possible. That’s always the goal,’ says Dr. Ataga, director of the Center for Sickle Cell Disease and chief of Hematology at UT Health Sciences.
Over more than two decades, he has led clinical trials that produced FDA-approved treatments, built care programs serving patients across the region, and watched patients transform their lives after receiving disease-modifying therapies. One patient he treated went on to become a sickle cell researcher and advocate himself.
On the eve of World Sickle Cell day, read more about how Dr. Ataga and his team continue to push for better outcomes for a population that faces unpredictable pain, organ complications, and an average life expectancy of just 48 years.”
More posts about UT Health Sciences.